Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00055315 · ClinicalTrials.gov registry record · NA
Treatment for Borderline Personality Disorder
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 383
- Enrollment target
NCT00055315: Completed NA study, sponsored by University of Iowa.
NCT00055315 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 383 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00055315, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 383 participants
- Enrollment target
Study Summary
This study will expose patients to either a Systems Training for Emotional Predictability and Problem Solving (STEPPS) or treatment as usual (TAU) to determine the more effective therapy for treating borderline personality disorder.
Interventions
- BEHAVIORAL Treatment As Usual (TAU)
- BEHAVIORAL Systems Training for Emotional Predictability and Problem Solving (STEPPS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2002-07 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT00055315 record still lists
NCT00055315 is an interventional study that assigns participants to a tested intervention. The registered 383 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Treatment As Usual (TAU) is the first listed.
NCT00055315 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00055315 about?
NCT00055315 is a clinical study titled "Treatment for Borderline Personality Disorder". This study will expose patients to either a Systems Training for Emotional Predictability and Problem Solving (STEPPS) or treatment as usual (TAU) to determine the more effective therapy for treating borderline personality disorder.
What is the current status of trial NCT00055315?
This trial is currently completed. It is a NA study. The enrollment target is 383 participants. The study started on 2002-07. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00055315?
The interventions under investigation include: Treatment As Usual (TAU) (BEHAVIORAL), Systems Training for Emotional Predictability and Problem Solving (STEPPS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00055315?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00055315's enrollment target sits among peer trials
383 273rd of 2000 higher than 1,728 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06056830 · 383 participants · Phase 3
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- NCT06277661 · 384 participants · NA
The Mom and Infant Outcomes (MOMI) Study
- NCT06372964 · 384 participants · Phase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- NCT06501040 · 384 participants · NA
Increasing Knowledge and Interest in Cancer Clinical Trials
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia